Search results for "Vaccination"


 
Results 101 - 110 of about 515 for "Vaccination".
Sort by: Relevance | Newest | Oldest

ACIP releases updated vaccination schedule with several changes

Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) affect vaccinations for influenza and human papillomavirus, among others.
https://immattersacp.org/weekly/archives/2020/02/04/1.htm
4 Feb 2020

CDC recommendations on COVID-19 vaccine boosters, new data on vaccine effectiveness

Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
https://immattersacp.org/weekly/archives/2021/09/28/1.htm
28 Sep 2021

Latest on COVID-19 and bamlanivimab, vaccines, long-term effects

Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021

More booster authorizations, research on vaccine safety and uptake

The FDA and CDC endorsed boosters of the Johnson & Johnson and Moderna vaccines. Recent research showed that COVID-19 vaccination was not associated with miscarriage, and a small financial incentive for receiving a COVID-19 vaccine or providing transportation to a vaccination site increased uptake.
https://immattersacp.org/weekly/archives/2021/10/26/1.htm
26 Oct 2021

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021

First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more

The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020

New guidelines on COVID-19 antibody testing, flu vaccination and trial data on remdesivir

Infectious diseases experts offered guidance on the use of antibody tests in practice, a remdesivir trial showed disappointing results, the CDC recommended flu vaccination for people six months and up, and a study reported post-ICU outcomes of patients with COVID-19.
https://immattersacp.org/weekly/archives/2020/08/25/1.htm
25 Aug 2020

ACP releases guidebook on aging, immunity, and importance of vaccination

A free guidebook reinforces the importance of immunization among older adults, especially for vaccine-preventable diseases such as shingles, pneumonia, and influenza.
https://immattersacp.org/weekly/archives/2017/12/19/4.htm
19 Dec 2017

ACP observes National Influenza Vaccination Week, offers resources to physicians

The latest recommended immunization schedule for adults was reviewed and approved in part by ACP and is available online from Annals of Internal Medicine, as are other resources to help increase immunization rates.
https://immattersacp.org/weekly/archives/2017/12/05/6.htm
5 Dec 2017

Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data

Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021

Result Page: Prev   6   7   8   9   10   11   12   13   14   15   Next